Photopheresis (extracorporeal photochemotherapy, ECP) is a new type of
photochemotherapy used for the treatment of oncological and autoimmune diseases …

Background. Graft-versus-host disease (GVHD) is a major complication after bone marrow
transplantation, which may be refractory to immunosuppressive drugs. As preliminary case …

Abstract Extracorporeal photochemotherapy (ECP; photopheresis), an immunomodulatory
therapy developed for cutaneous T‐cell lymphoma, has shown promise in treating chronic …

Photopheresis is an extracorporeal photochemotherapy (ECP) used for the treatment of
oncological and autoimmune diseases. Lymphocytes are drawn from the patients by …

Extracorporeal photochemotherapy (ECP; photopheresis), an immunomodulatory therapy,
has previously demonstrated promising results in treating chronic graft-versus-host disease …

The aim of our study was to assess the efficacy of extracorporeal photopheresis (ECP) in
chronic graft-versus-host disease (GVHD). Eleven patients with chronic cutaneous GVHD …

Acute and chronic graft-versus-host disease (GVHD) continue to be major limitations to
successful hematopoietic stem cell transplantation. A variety of different immunosuppressive …

Extracorporeal photochemotherapy (ECP) has been progressively introduced into the
treatment of both acute and chronic graft‐versus‐host disease (cGvHD) over the last …

Pediatric experience with extracorporeal photochemotherapy (ECP) for graft-versus-host
disease (GvHD) has mainly been reported by Italian and French groups. Data concerning 41 …

Extracorporeal exposure of peripheral blood mononuclear cells to the photosensitizing
compound 8-methoxypsoralen and ultraviolet A radiation has been shown to be effective in …